A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals
To access this article, please choose from the options below
PII: S0168-8278(10)00550-7
doi:10.1016/j.jhep.2010.05.007
© 2010 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
